Transgene S.a annual debt-to-equity ratio
2021
2022
2023
2024
2025
Transgene S.a Debt-to-Equity Ratio Growth & History (TNG)
Transgene S.a's debt-to-equity ratio was 0.02 for fiscal 2025.
View full Transgene S.a company overviewTransgene S.a annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.02 | −0.67 | −97.53% |
| 2024 | 2024-12-31 | 0.68 | −0.42 | −38.28% |
| 2023 | 2023-12-31 | 1.11 | 0.75 | +210.08% |
| 2022 | 2022-12-31 | 0.36 | 0.11 | +44.33% |
| 2021 | 2021-12-31 | 0.25 | — | — |
Transgene S.a quarterly debt-to-equity ratio
Q4.24
Q4.25
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 0.00 | −0.00 | — |
| Q4 2024 | 2024-12-31 | 0.00 | — | — |
Transgene S.a debt-to-equity ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Transgene S.a's debt-to-equity ratio decreased from 0.25 to 0.02, a change of −0.23. The latest reported quarter, Q4 2025, shows 0.00.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Transgene S.a source filings ↗